|Beijing Hope Pharmaceutical Co., Ltd. (stock symbol: 836438), which was founded in 2005, is a high-tech pharmaceutical enterprise dedicated to R&D of chemical drug. The head office and R&D centre of Hope are located in Beijing Economic-Technological Development Area (BDA). The main business are R&D, technology transfer and technical services of APIs and pharmaceutical preparations,R&D, manufacture and sales of PIs. Moreover, Hope has the right of dealing self-managed imp&exp business.|
Hope has a high-level R&D team and a strict R&D, manufacture and service management system. Depending on many years of technology accumulation, Hope has been designated as “high-tech enterprise” and “Beijing scientific and technological organization for R&D”.
Hope has always been adhering to the technology-oriented, talent-based policy since its establishment. By a huge investment in R&D of new drugs for the treatment of tumor, depression, cardio-cerebrovascular diseases, gastrointestinal diseases, respiratory disease, etc., Hope has attained multiple research achievements (over 10 patent applications, over 10 new drug certificates and manufacture permission letters, over 40 clinical trial permission letters). Hope will constantly offer its clients the highest-quality products, technologies and services. With the purpose of improving national health, promoting development of pharmaceutical industry, Hope will make unremitting efforts and contribute its own strength.
Beijing HMT Medical Technology Co., Ltd. (HMT) is a wholly owned subsidiary of Hope specialized in R&D, manufacture, sales of Pharmaceutical Intermediates (PIs) and is oriented towards the global market. Depending on many years’ experience in drug R&D and registration, we can provide our client not only the high-quality products, but also comprehensive technical and document support to assist them in solving the problems.Tigecycline Intermediates price
0 条回复 | 直到 13天前 | 13 次浏览